Controlling sialorrhoea: a review of available treatment options
Authors:
- 8 August 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 6 (9) , 1551-1554
Abstract
Sialorrhoea (drooling or excessive salivation) is a common symptom of many neurological diseases (e.g., amyotropic lateral sclerosis, cerebral palsy and Parkinson’s disease) and otolaryngologic diseases (tumours of upper aerodigestive tract). It is mostly caused by poor oral and facial muscle control in patients with swallowing dysfunction (secondary sialorrhoea). However, some cases of sialorrhoea are due to hypersecretion of saliva. These cases represent so-called primary sialorrhoea.Keywords
This publication has 18 references indexed in Scilit:
- Therapie der Clozapin-induzierten Hypersalivation mit Botulinum-Toxin BDer Nervenarzt, 2005
- Recurrent Pneumoparotid: Cause and TreatmentOtolaryngology–Head and Neck Surgery, 2004
- Reduction of Salivary Flow With Botulinum Toxin: Extended Report on 33 Patients with Drooling, Salivary Fistulas, and SialadenitisThe Laryngoscope, 2004
- Botulinum toxin as an effective treatment of clozapine-induced hypersalivationPsychopharmacology, 2004
- Reduction Of Clozapine-Induced Hypersalivation By Pirenzepine Is SafePharmacopsychiatry, 2004
- Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s diseaseClinical Neurology and Neurosurgery, 2004
- Scolpolamine Patch for Clozapine-Induced SialorrheaPsychiatric Services, 2004
- Clozapine-Induced Sialorrhea Treated With Sublingual Ipratropium SprayJournal of Clinical Psychopharmacology, 2004
- Management of droolingSeminars in Pediatric Neurology, 2003
- ‘Management of drooling: 10 years after the Consortium on Drooling 1990’Developmental Medicine & Child Neurology, 2003